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throughput screening. This procedure produced an intriguing primary sequence whose structure-function analysis is described
here. The alternating pattern of hydrophilic and hydrophobic amino acids suggests the possibility that SB056 is a membrane-
active peptide that forms amphiphilic b-strands in a lipid environment. Circular dichroism confirmed that the cationic SB056 folds
as b-sheets in the presence of anionic vesicles. Lipid monolayer surface pressure experiments revealed unusual kinetics of
monolayer penetration, which suggest lipid-induced aggregation as a membranolytic mechanism. NMR analyses of the linear
monomer and the dendrimeric SB056 in water and in 30% trifluoroethanol, on the other hand, yielded essentially unstructured
conformations, supporting the excellent solubility and storage properties of this compound. However, simulated annealing
showed that many residues lie in the b-region of the Ramachandran plot, and molecular-dynamics simulations confirmed the
propensity of this peptide to fold as a b-type conformation. The excellent solubility in water and the lipid-induced oligomerization
characteristics of this peptide thus shed light on its mechanism of antimicrobial action, which may also be relevant for systems
that can form toxic b-amyloid fibrils when in contact with cellular membranes. Functionally, SB056 showed high activity against
Gram-negative bacteria and some limited activity against Gram-positive bacteria. Its potency against Gram-negative strains was
comparable (on a molar basis) to that of colistin and polymyxin B, with an even broader spectrum of activity than numerous other
reference compounds.INTRODUCTIONVirtually all multicellular organisms rely on antimicrobial
peptides (AMPs) to ward off pathogenic microbes (1).
They are part of the innate immune system and in particular
play a crucial role in organisms (the vast majority) that have
not developed a more-sophisticated adaptive immune
system. Even in higher vertebrates (including humans),
AMPs such as defensins not only have direct microbicidal
activity but also serve as signals that initiate, mobilize,
and amplify adaptive immune host defenses (2). Much
attention has been devoted in the last two decades or so to
AMPs as a source of new anti-infective drugs, which are
urgently needed to combat the growing bacterial resistance
to conventional antibiotics (3). Beyond pure anti-infective
activity, the potential therapeutic role of AMPs has been
significantly broadened by an appreciation of their immuno-
modulatory properties (4). Although AMPs display a bewil-
dering variety in their primary sequences, they generally
share a cationic character and a globally amphipathic fold,
with clearly distinguishable hydrophilic and hydrophobic
faces. These structural features reflect their mode of action,
which is primarily directed toward interacting with and
damaging the target cell’s plasma membrane (5). However,
despite intense efforts to elucidate the mechanisms of actionSubmitted August 22, 2011, and accepted for publication January 30, 2012.
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0006-3495/12/03/1039/10 $2.00of AMPs, their exact roles in host defense, and possible
ways of harnessing their therapeutic potential, little
practical outcome has been achieved as yet. Naturally
occurring AMPs have numerous drawbacks that limit their
development into therapeutically applicable antibiotics,
including their susceptibility to protease degradation, the
high costs of manufacturing, and reduced activity in the
presence of salts and divalent cations, such as those present
in serum.
To overcome these problems, many researchers have
developed mimics or peptidomimetics that are endowed
with improved properties but retain the basic features of
natural membrane-active AMPs, such as amphipathic design
and cationic charge. Protein epitope mimetics, oligoacylly-
sines, ceragenins, synthetic lipidated peptides, peptoids,
and other foldamers are only some of the routes explored
so far (6,7). Among the various biomimetic approaches,
multimeric peptides have recently received some attention
(8–10). These so-called dendrimers are branched polymers
in which peptides are attached centrally to a template or
core matrix. Compared with their monomeric counterparts,
dendrimeric peptides usually display increased activity,
which is usually attributed to the higher local concentration
of bioactive units in such polyvalent assemblies, as well as
greater stability against peptidases and proteases.
Our goal in this study was to thoroughly characterize
a semisynthetic peptide with a lipidated dimeric scaffold,doi: 10.1016/j.bpj.2012.01.048
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activity against a wide range of bacteria and examined
possible modes of interaction with model membranes.
SB056 is a dendrimer with an entirely novel design that
is meant to increase its performance against bacterial
targets. To acquire detailed information about the struc-
ture-function relationship that governs its putative
membrane interactions and antimicrobial activity, we
compared the dendrimeric SB056 with the linear monomer
throughout our studies. In this way, we expect to elucidate
the exact role played by the dendrimeric scaffold and
understand its significance for the peptide’s mode of action.
Inspection of the peptide sequence, which was previously
obtained by semi-empirical optimization after high-
throughput screening of a phage library (11), surprisingly
revealed a striking pattern of charged and hydrophobic
amino acids. With the exception of the first two residues,
the sequence [WKKIRVRLSA] consists of alternating
hydrophobic and cationic/polar amino acids. In this
respect, it resembles the designer-made b-stranded model
sequence [KIGAKI]3 (12) and several other peptides that
are known to form b-sheets (see below). We thus predict
that both SB056 and its linear monomer can form amphi-
philic b-strands when in contact with a lipid bilayer, and
we set out to verify this hypothesis as described below.
Overall, the collected evidence provides a key for under-
standing the functional mechanism of SB056, and thus
will allow further rational optimization of the dendrimeric
agent.MATERIALS AND METHODS
Details regarding synthesis and determination of antimicrobial activity are
provided in the Supporting Material.FIGURE 1 Molecular structure of SB056. Primary sequence and chemi-
cal structure of the dendrimeric (dimeric) AMP SB056. All of the amino
acids have an L configuration, and 8-Aoc is 8-aminooctanoic acid, which
is amidated in the SB056 construct. The monomeric peptide is amidated
at the C-terminus.
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For CD spectropolarimetry, weighed amounts of the linear monomer or the
dendrimeric SB056 were dissolved in 10 mM phosphate buffer to prepare
stock solutions with concentrations of 50–200 mM. For further details on
the sample preparation and CD spectra recording and analysis, see the
Supporting Material.NMR characterization
For liquid-state NMR structure analysis, both the dendrimeric and linear
SB056 were dissolved at 1 mM concentration in 100% D2O (99.98% D;
Sigma-Aldrich, St. Louis, MO), 10 vol% D2O in deionized H2O, or
30 vol% trifluoroethanol (TFE, 99.5% D; Sigma-Aldrich) in deionized
H2O. In water, the final pH came to ~6.0 at 298 K and was adjusted to
4.0 with small aliquots of HCl or NaOH 0.1 M to slow down the exchange
of backbone amide protons with the solvent (13). See the Supporting
Material for details on the NMR spectra recording and analysis.Molecular-dynamics simulations
We obtained the peptide structures via a simulated annealing protocol using
experimental NMR parameters as restraints, and ran molecular-dynamics
(MD) simulations as described in the Supporting Material.Surface-pressure measurements of peptide
penetration in lipid monolayers
The insertion of the peptides into lipid monolayers was examined by means
of a surface-pressure analysis as an indication of their ability to bind and
penetrate microbial plasma membranes, as described in the Supporting
Material.RESULTS
Determination of the minimum inhibitory
concentration
The in vitro activity of SB056 and of numerous reference
compounds was determined against ATCC strains and an
expanded panel of recently collected clinical isolates (Table
S1). All of the tested strains show resistance to several
currently used antibacterial agents. SB056 has a good
activity against Acinetobacter baumannii, Enterobacter
cloacae, Escherichia coli, Klebsiella pneumoniae, Pseudo-
monas aeruginosa, and Stenotrophomonas maltophilia,
with minimum inhibitory concentration (MIC) values in
the range of 2–32 mg/ml. Against Proteus mirabilis and
Serratia marcescens, SB056 exhibits higher MIC values
of 32–>128 and >128 mg/ml, respectively. Polymyxin B
shows an antibacterial potency similar to that of colistin,
with MIC values lower than those of SB056, although the
potency in terms of molarity is comparable (Table S2).
The activities of SB056 against the Gram-positive bacteria
Enterococcus faecalis, E. faecium, Staphylococcus epider-
midis, and S. aureus are reported in Table S3. The dendri-
meric peptide reveals a limited activity against enterococci
with MIC values in the range of 8–128 mg/ml; against
S. aureus the MIC range is 32–64 mg/ml, and against
Structure-Function Analysis of SB056 1041S. epidermidis the MIC value is 8 mg/ml. Colistin is not
active against all Gram-positive strains tested, and poly-
myxin B is active only against S. epidermidis (32 mg/ml).
A limited activity of SB056 against Mycobacterium
smegmatis (MIC 64 mg/ml) and no activity against Candida
spp. is observed (Table S4). Finally, in Table S5 we present
a direct comparison between the activity of the dendrimeric
SB056 and the linear monomer against standard Gram-
negative and -positive reference strains. The MIC values
of SB056 are decreased by several dilution steps, which
clearly indicates the advantage of turning the linear mono-
mer into the dendrimeric lipidated SB056.CD structural analysis of the linear monomer
and the dendrimeric SB056
We characterized the secondary structures of the linear
monomer and the dendrimeric SB056 by circular dichroism
(CD) to obtain a qualitative overview of their conforma-
tional preferences over a range of different conditions.
These included unilamellar lipid vesicles of the same
composition as used as in the subsequent surface-pressure
experiments, as well as the widely used membrane-
mimicking TFE/water mixtures to be used in the parallel
NMR analysis. Fig. 2 shows the CD spectra of SB056 (linear
and dendrimeric) measured in small unilamellar vesicles
(SUVs) composed of DMPC or of DMPC/DMPG 1:1. In
the presence of zwitterionic DMPC, the characteristic
random coil lineshape suggests a mostly unordered structure
for both peptides (see secondary structure estimation in
Table S6), which is similar to the situation in pure phosphate
buffer (see Fig. S1, Table S7, and Table S8). In anionic
DMPC/DMPG liposomes, on the other hand, a pronounced
conformational change is observed for the cationic peptides.
The monomer shows a diminished mean residue ellipticity
with two shallow minima at ~200 and 215 nm, and a smallFIGURE 2 CD spectra of the linear monomer and the dendrimeric
SB056 in the presence of membranes. Peptides were added to SUVs of
DMPC and DMPC/DMPG (1:1) at a peptide/lipid ratio of 1:100. The
lineshape of both peptides in zwitterionic DMPC is characteristic of an
unordered conformation, whereas the spectra in anionic DMPC/DMPG
show a combination of b-sheet, b-turn, and unordered fractions.positive Cotton effect around 190 nm. Even more pro-
nounced is the change for the dendrimeric SB056, which
exhibits a strong negative band at 195 nm, a broad positive
band at ~206 nm, and a less intense negative band below
220 nm. These spectral features clearly point to a mixture
of b-sheet and b-turn, plus some unordered fraction. The
quantitative secondary structure analysis of the data in Table
S6 supports a substantial b-sheet content of 34% and 47%,
plus b-turn fractions of 22% and 28%, for the linear mono-
mer and the dendrimeric SB056, respectively. In agreement
with the surface pressure data (see below), the excess of
anionic DMPG charges in the vesicles obviously leads to
electrostatic attraction of the cationic peptides. Once they
are bound, the lipid environment induces a predominant
b-type conformation, which is more pronounced for the
dendrimeric SB056 than for the monomer. Because these
fractions are taken on a mean residue ellipticity basis (and
not on a total weight basis as in the MIC tests), they reflect
the intrinsic tendency of the peptide chains to fold. Analo-
gous CD measurements in the presence of 30% TFE (see
Fig. S1) showed a preferential a-helical conformation,
which is not unexpected because TFE is well known as
a helix-inducing solvent (14). In contrast to the NMR exper-
iments shown below, the CD measurements were carried out
with low peptide concentrations (5–50 mM), where aggrega-
tion is of no concern (in the absence of a lipid bilayer
surface). The CD results obtained in 30% TFE thus provide
the secondary structure of monomeric (i.e., not aggregated)
peptides in solution.NMR characterization
We used 1H-NMR to analyze the structures of the dendri-
meric SB056 and the linear monomer in more detail.
To mimic a membrane environment, we first attempted to
dissolve SB056 in SDS detergent micelles, but this led to
the rapid formation of aggregates that were unsuitable for
NMR. We therefore compared the peptides in pure water
and in 30 vol% TFE, which was the minimum TFE concen-
tration that induced any significantly ordered conformation
in our CD analysis (see Fig. S1). Compared with the
CD measurements at very low peptide concentrations (5–
50 mM), however, the NMR analysis was carried out with
much higher concentrations (~1 mM). Although we
observed no tendency for aggregation in TFE by CD, it is
conceivable that intermolecular interactions may occur
under NMR conditions due to the 100-fold higher con-
centration. Indeed, the first signs of peptide aggregation
become apparent during these experiments: over a period
of several days/weeks the TFE-containing NMR sample
turned cloudy, and after prolonged storage we observed
a fine precipitate at the bottom of the tube. Even though
TFE is often regarded as a helix-inducing solvent (14), in the
context of a peptide-peptide self-assembly equilibrium
TFE can be expected to shift the system toward theBiophysical Journal 102(5) 1039–1048
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a-helical or b-sheeted (15). The main effect of TFE is to
enhance the formation of intra- and intermolecular
hydrogen bonds, because the TFE molecules preferentially
cluster around the peptide backbone, replacing the water
(16–18).
On the basis of correlation spectroscopy (COSY) and
total correlation spectroscopy (TOCSY) spectra, acquired
both in pure water and in 30% TFE, all proton resonances
from the linear monomer and the dendrimeric SB056 were
assigned (Table S9). These results show neither significant
differences between the linear monomer and the dendri-
meric SB056 nor significant deviations from the random
coil values in water (19). The values of 3JHNHa scalar
coupling constants were obtained directly from the one-
dimensional spectra to estimate the average values for the
corresponding backbone F angles. In all cases, they are
found to lie in the 5.5–7.1 Hz range, with a slight increase
upon moving from water to 30% TFE, and hence they
may reflect motional averaging of multiple conformations
(13). Nevertheless, certain differences are observed in the
rotational nuclear Overhauser effect spectroscopy (ROESY)
and nuclear Overhauser effect spectroscopy (NOESY)
spectra. Although no sequential crosspeaks were found for
either peptide in pure water, some interesting 1HaN(i,iþ1)
signals could be assigned in 30% TFE, as shown in
Fig. S2. However, no 1HNN(i,iþ1) signals, which are gener-
ally expected in the case of a stable a-helical conformation
(13,19), are observed. The dipolar interactions pattern turnFIGURE 3 1H-NMR analysis of F and J backbone angles on a Ramachan
A simulated annealing procedure was applied on both peptides, using 3JHNHa s
to restrain the F backbone angles and interproton distances, respectively. In
One hundred structures with the lowest potential energy were selected and anal
plot were obtained for the linear peptide (A) and the dendrimeric SB056 (B). Re
are indicated as bordered areas. Shaded regions represent the most common back
structure.
Biophysical Journal 102(5) 1039–1048out to be almost comparable for the two peptides, but they
show slight differences at the C-terminus. In the case of
the dendrimeric SB056, daN(i,iþ1) signals are observed
without interruption along the entire sequence from K3 to
L8 (and from K13 to L18 as defined on the other peptidic
branch). On the other hand, the linear monomer shows
daN(i,iþ1) from K3 to R7, as well as daN(i,iþ1) and
dbN(i,iþ1) between S8 and L9, which are absent in the
dendrimeric SB056. Moreover, a medium-range dipolar
interaction is observed between 8L-HN and 10A-Hb. These
results suggest a reduced mobility of the two peptides in
30% TFE compared with pure water. In particular, the linear
monomer seems to form a kind of turn at the C-terminus,
which is hindered in the dendrimeric SB056, presumably
due to the attachment to the lysine linker and the resulting
reduction in backbone flexibility.
As described in the Supporting Material, we applied
a simulated annealing procedure to both peptides using
the 3JHNHa scalar couplings and the ROE and NOE intensi-
ties as experimental parameters to restrain the F backbone
angles and interproton distances, respectively. One hundred
structures with the lowest potential energy were selected
and analyzed. Fig. 3 summarizes the distribution of F and
J backbone angles on the Ramachandran plot. Of interest,
for both peptides, all residues between K3 and R7 (defined
as K13–R17 in the second peptidic branch) lie in the b region
of the plot. Fig. 4 shows a representative structure of the
linear monomer and the dendrimeric SB056, i.e., with
the lowest root mean-square deviation (RMSD) from thedran plot for the linear monomer and the dendrimeric and linear SB056.
calar couplings and the ROE/NOE intensities as experimental parameters
particular, daN(I,iþ1) provided the restraints for the J backbone angles.
yzed. The distributions of backbone F and J angles on the Ramachandran
gions typically allowed for all the standard amino acids (except for glycine)
bone conformations corresponding to the b-pleated and a-helical secondary
FIGURE 4 NMR-derived structures of the linear monomer (A) and the
dendrimeric SB056 (B). For each peptide, the structure with the lowest
RMSD from the average backbone conformation was obtained from a simu-
lated annealing procedure with NMR-derived restraints.
FIGURE 5 Ramachandran plots obtained from MD simulations. (A)
Linear peptide in water. (B) Dendrimeric SB056 in water. (C) Linear
peptide in 30% TFE. (D) Dendrimeric SB056 in 30%. The bar on the right
Structure-Function Analysis of SB056 1043computed average backbone conformation. A kind of coiled
conformation of the N-terminus in both cases, as well as
a turn at the C-terminus of the linear monomer, can be
observed (Fig. 4). However, the error bars reported in
Fig. 3 clearly emphasize the random-coil nature of both
peptides, even in 30% TFE, in good agreement with the
CD analysis (see also Supporting Material).represents the probability increasing from 0 to 1.MD simulations
It is important to note that the MD simulations were per-
formed without NMR-derived restraints. Backbone RMSDs
from the initial structure (Fig. S3) were higher, on average,
in water than in 30% TFE for both peptides. Moreover, the
residue root mean-square fluctuations (RMSFs; Fig. S4)
indicate a lower conformational flexibility for both peptides
in 30% TFE compared with pure water. In particular, it is
interesting to note that the fluctuations of the two peptidic
branches of the dendrimeric SB056 become comparable in
30% TFE, i.e., the essentially same results are obtained
for homologous residues located in the two branches, in
contrast to the situation observed in pure water (Fig. S4
B). The MD results for the backbone F and J angles are
consistent with these observations and with the NMR
results. The F/J distributions obtained for the linear mono-
mer in water and in 30% TFE are shown in Fig. S5, under
the same conditions as employed for the NMR experiments,
and in Fig. S6 for the dendrimeric SB056.
Comprehensive Ramachandran plots are reported in
Fig. 5. In water, all four quadrants are significantly populated
for each of the two peptides, which is indicative of a random-
coiled structure. Even though the b region is most populated,
both backbone angles show considerable fluctuations,
ranging from ~60 to 130 in F, and from ~90 to 160
in J. All residues exhibit a kind of bimodal distribution in
these two ranges (Fig. S5 and Fig. S6) with maximum
probabilities of ~70 and 120, and ~100 and 140,
respectively. This finding results in four combinations, which
are almost equally populated (Fig. 5, A and B). Of interest,
upon moving to 30% TFE, both positive F and negative J
contributions decrease. Moreover, backbone angles dis-tributions in the b region change dramatically and retain
only two significant maxima in the Ramachandran plot
at ~120/150 and 80/90. From residues K3–R7 (and
K13–R17), both backbone F andJ angles follow a kind of
alternating pattern whose maxima are already observable in
pure water, whereas the distributions of K2, L8, and S9
turn out to be comparable in the two solvents investigated.
This suggests that the addition of 30% TFE does indeed act
in the context of a preexisting equilibrium, leading the
peptide toward a preferred smaller set of conformations
(15), in agreement with the NMR observations. Moreover,
although the backbone angle distributions for homologous
residues in the two peptidic chains of the dendrimeric
SB056 are remarkably different in pure water, in 30% TFE
they are almost identical to one another and comparable to
the linear monomer. This finding is consistent with the
RMSF values of the residues (Fig. S4) and supports the
ordering role of TFE in this study.SB056 insertion into lipid monolayers
To gain further insight into the behavior of SB056 and the
linear monomer in a membrane-like environment, we
explored the interactions of these peptides with lipid mono-
layers by surface pressure analysis (20,21). As in the CD
analysis, DMPC and DMPC/DMPG (50:50, w/w) were
used to mimic neutral and anionic membranes. Both
SB056 and the linear monomer efficiently penetrated into
both of these monolayers, as demonstrated by the increase
in film surface pressure p0. A large number of measure-
ments, starting from a wide range of different initial surfaceBiophysical Journal 102(5) 1039–1048
FIGURE 6 Intercalation of the linear monomer
and dendrimeric SB056 into lipid monolayers.
Peptide insertion into DMPC and DMPC/DMPG
(1:1) was monitored from the increase in the
surface pressure of lipid monolayers upon addition
of 1.0 mM of the linear monomer (A) or the dendri-
meric SB056 (B) into the subphase, as a function of
initial surface pressure. In C and D, the same data
are shown regrouped to allow a direct comparison
between the two peptides in the different lipid
systems.
1044 Scorciapino et al.pressures, are summarized in Fig. 6, showing a general trend
for both peptides and both lipid compositions. We see that
the incorporation of peptide into the monolayer decreases
with increasing initial values of p0, as expected in view of
the greater packing density of the lipid chains at higher pres-
sures. In the plots of Dp as a function of p0, the monolayer
exclusion pressure can be derived by extrapolating the
Dp-p0 slope to Dp ¼ 0. This critical surface pressure
corresponds to the lipid lateral packing density at which
the intercalation of a peptide into the lipid film is prevented.
In DMPC it has a value of 38 mN/m and 45 mN/m for the
linear monomer and the dendrimeric SB056, respectively
(Fig. 6, A and B). In the case of DMPC/DMPG, these values
increase to 59 mN/m and 51 mN/m, respectively (Fig. 6, A
and B). By replotting the same data in Fig. 6, C and D, for
the two lipid systems, we can clearly appreciate that the
membrane activity of the cationic peptides is enhanced by
the presence of anionic DMPG. As in the case of many other
cationic AMPs, electrostatic binding plays an important role
in peptide-membrane interactions. We also note that SB056
with 10 positive charges displays an overall stronger interca-
lation activity than the linear monomer with only five
charges. This difference is most pronounced in DMPC/
DMPG at low p0-values, with an interesting crossover point
at a surface pressure of ~39 mN/m (Fig. 6 D), and signifi-
cantly lower penetration is observed in DMPC for all p0-
values (Fig. 6 C).
The kinetics of the insertion of the peptides into lipid
monolayers were monitored over a period of ~30 min, and
showed rather unusual time-courses for SB056 and the
linear monomer. In Fig. S7 the curve of the linear monomer
displays a rather constant increase in p0 with time, andBiophysical Journal 102(5) 1039–1048within the timeframe of measurement no stabilization was
reached. The curve of SB056 (Fig. S7 B) is characterized
by a relatively fast peptide intercalation after injection
into the subphase, followed by a gradual stabilization of
p0, yet no plateau is reached. These slow, nonasymptotic
kinetic patterns of intercalation differ fundamentally from
those recorded previously for other cationic amphiphilic
AMPs, such as the a-helical temporins and bombinins H
from frog skins (21,22). Representative curves of the latter
two peptides are shown in Fig. S7, C and D, respectively,
for comparison. They are characterized by an explosive
initial rise immediately after peptide addition, followed by
an almost complete stabilization. This behavior indicates
that the usual process of peptide binding and insertion into
the monolayer is extremely rapid, with hardly any sign of
structural relaxation or peptide reorganization. In the case
of SB056 and particularly of its linear monomer, however,
the whole process of peptide-membrane interaction seems
to be considerably slower. Significantly more time is needed
for the system to approach equilibrium, which in the case of
the linear monomer is not even reached within the acces-
sible timeframe of the experiment (i.e., before evaporation
effects start to dominate).
In summary, the monolayer experiments revealed that
both the linear monomer and the dendrimeric SB056 are
indeed membrane-active, with SB056 displaying a stronger
intercalation and faster kinetics than the linear monomer.
These findings, together with the fact that monolayer pene-
tration is enhanced by the presence of anionic DMPG,
further support the idea that, just like the vast majority of
AMPs studied so far, SB056 could also exert its antimicro-
bial activity by perturbing the plasma membrane of the
Structure-Function Analysis of SB056 1045target cell, with electrostatic binding playing an important
role in the initial peptide-membrane interactions. The
particular intercalation kinetics are rather different from
and significantly slower than those recorded previously for
a-helical peptides (21,22). The unusual surface-pressure
curves most likely reflect some lateral peptide aggregation
in the plane of the membrane, which is more efficient for
SB056 than for the linear monomer. This difference makes
sense, given that the two branches of the dimeric SB056 can
cross-interact with one another and with neighboring
peptides either before and/or during penetration of the
membrane. Such behavior is expected to lead to a network
of interacting b-strands with a high b-sheeted content.DISCUSSION
The novel AMP discussed here, SB056, belongs to the class
of peptide dendrimers (branched polymers with peptides
attached to a central template or core matrix). Dendrimer
applications include immunogens and antigens, protein
mimetics, de novo design of artificial proteins, new biopoly-
mers, and biomaterials (23). The introduction in the late
1980s of the multiple antigenic peptide (MAP) system for
the preparation of peptide immunogens was a significant
advance in the field of multimeric peptides (24). With the
use of MAP, multiple peptide sequences can be added to
an inner core of radially branched lysine residues by stan-
dard solid-phase chemistry.
The peptide sequence of SB056 was derived by rational
modification and optimization of an AMP [QEKIRVRLSA]
that was originally identified by selecting a random phage
library against whole E. coli cells (11). As a distinctive inno-
vative feature, SB056 carries a short lipophilic chain to
increase its membrane activity. We recently exploited the
MAP approach to develop other peptide dendrimers with
antimicrobial properties. SB041, a tetra-branched peptide
carrying four identical sequences [pyrEKKIRVRLSA] on
a lysine core, was found to be particularly active against
Gram-negative strains, and it strongly bound E. coli and
P. aeruginosa LPS in vitro, although this binding did not
translate into LPS-neutralizing activity (10). Another recent
study (8) showed that peptide-derivatized dendrimers have
the potential for other anti-infective applications besides
targeting bacterial pathogens. The tetra-branched compound
SB105 and its derivative SB105-A10 were able to inhibit
replication of several strains of human cytomegalovirus in
both primary fibroblasts and endothelial cells, apparently
by blocking the initial attachment of the virion to heparan
sulfate on the cell surface. This mode of action appears to
represent a novel mechanism that could make SB105 and
its derivatives attractive candidates as members of an inno-
vative class of antiviral drugs.
The results reported here for SB056 collectively show
that this novel lipodimeric dendrimer displays excellent,
albeit selective, antimicrobial activity, whereas its linearcounterpart is only poorly active against most of the tested
strains. This study thus confirms the advantage of a dendri-
meric scaffold compared with isolated sequences. As was
previously demonstrated for SB041, SB056 was active
against Gram-negative bacteria, and it even retained some
activity against Gram-positive strains. Although the potency
of SB056 against Gram-negative bacteria was comparable
to that of colistin and polymyxin B (on a molar basis), its
spectrum of antimicrobial activity was even broader than
that displayed by these two reference compounds, which
are completely inactive against Gram-positive strains. Thus,
the lack of broad-spectrum activity displayed by SB056
could be due to its preferential interaction with components
of the outer membrane of Gram-negative bacteria, such as
LPS, for which the comparable SB041 was previously
demonstrated to have good affinity (10). On the other
hand, SB056’s residual activity toward Gram-positive
strains could be explained by its inherent tendency to bind
and perturb anionic lipid membranes.
The primary sequence [WKKIRVRLSA] of the peptidic
part of SB056 reveals a striking pattern of alternating hydro-
philic and hydrophobic amino acids, with the exception
of the first two residues. Even though this basic pattern
emerged from a random phage display library, its amphi-
philic features are reminiscent of the model peptide
[KIGAKI]3, which was designed as an amphiphilic b-strand
(12). Of interest, this artificial b-stranded model peptide ex-
hibited a high antimicrobial activity. Its structure was exper-
imentally confirmed to be b-pleated in the presence of
membranes (25), and extensive aggregation into extended
b-sheets was recently demonstrated by solid-state NMR
(26). We therefore predicted that the SB056 peptide might
also be able to fold in a similar way. The comparative CD
structure analysis of the linear monomer and the dendri-
meric SB056 showed that both peptides have a mostly
unordered conformation in aqueous solution and in the
presence of uncharged DMPC liposomes. In contrast, in
an anionic lipid environment both peptides assume predom-
inantly b-type conformations, which is more pronounced
for the dendrimeric SB056 than for the linear monomer.
We carried out more detailed analyses by NMR and MD
in water, and in 30% TFE as a membrane-mimicking
solvent. At low (micromolar) peptide concentrations, CD
showed that the monomeric (i.e., not aggregated) peptides
had a tendency to take on an a-helical conformation.
When measured at a 100-fold higher concentration by
NMR, however, intermolecular aggregation started to set
in. Both the linear monomer and the dendrimeric SB056
largely maintained a random-coil structure, and an inherent
folding tendency was discerned in the b-region of the
Ramachandran plot. Both NMR and MD point to a distinct
role of the more-hydrophobic environment provided by
30% TFE compared with pure water, which reduces the
conformational flexibility and pushes the preexisting
random-coil4ordered equilibrium toward its preferentialBiophysical Journal 102(5) 1039–1048
1046 Scorciapino et al.conformation. Specifically in the case of the dendrimeric
SB056, the two peptidic chains appear to have comparable
fluctuations in 30% TFE but not in pure water, thus support-
ing the ordering effect of TFE. However, because TFE is an
isotropic solvent, it does not trigger peptide aggregation to
any extent comparable to that of the amphiphilic surface
of a lipid vesicle. A genuine membrane environment leads
to a very high peptide concentration in the 2D plane and
induces a preordering of the amphiphilic sequences. These
two effects promote intermolecular b-strand aggregation,
which is something TFE cannot do in an isotropic solution.
Overall, we have collected multiple pieces of evidence
showing that the linear monomer and the dendrimeric
SB056 have a strong tendency to fold as b-structures, as
predicted from its primary amino-acid sequence with alter-
nating hydrophobic and hydrophilic residues. The intrinsic
preference to populate the b-region of the Ramachandran
plot, as revealed by NMR and MD analysis, is explicitly
confirmed by the CD data in anionic membranes and by
the observed rapid aggregation of SB056 induced by SDS.
Obviously, the presence of a lipid bilayer or a micellar
surface enhances the formation of amphiphilic b-strands
and aggregated b-sheets, provided that the cationic peptides
are electrostatically attracted to the structure-inducing inter-
face. Of note, SB056 exhibits a higher content of b-type
conformations than the linear monomer.
All of our observations reinforce the idea that SB056
may exert its antimicrobial action by interacting with lipid
membranes, and the branched dimeric structure of the den-
drimeric peptide would further facilitate the formation and
stabilization of such multimolecular aggregates within the
bilayer. Intriguingly, the tendency for AMPs to exist in
a semifolded or prefolded state in solution (i.e., before the
interaction with bacterial membranes) was previously noted
for a-helical peptides and correlated with antimicrobial
activity (27,28). Thus, a higher propensity to assume any
kind of folded conformation in aqueous solution seems to
facilitate, both thermodynamically and kinetically, complete
peptide folding in the membrane environment (6).
A number of naturally occurring and synthetic AMPs are
known to self-assemble into b-sheet in membranes, and
these AMPs may serve as a reference for SB056 and simi-
larly structured peptides. Natural examples are defensins
and protegrins with disulfide cross-linked structures (29).
Engineered sequences include some b-sheet pore-forming
peptides, selected from a combinatorial library based on
a 26-residue framework designed to mimic membrane-span-
ning b-hairpins (30). Investigators have characterized the
mechanism of action of these tailored peptides on both
model and biological membranes, and concluded that they
form pores by the so-called carpet-like or sinking-raft
models, as also observed for many natural pore-forming
AMPs (30,31). According to this mechanism, the mono-
meric peptides bind to the outer monolayer due to hydro-
phobic and electrostatic interactions, and subsequentlyBiophysical Journal 102(5) 1039–1048self-assemble on the membrane surface into peptide-rich
domains. This leads to destabilization of the bilayer and
transient leakage of vesicle contents. Much of this scenario
seems to apply also to SB056.
In conclusion, SB056 is a novel lipodimeric AMP with
high solubility and remarkable self-assembly properties,
supporting the potential of synthetic dendrimers. The pep-
tide shows a lipid-induced propensity to fold as an amphi-
philic b-strand and thereby self-assemble into b-sheets,
which may be present as aggregates as a branched network
and/or as amyloid-like fibrils. The conformational proper-
ties and oligomerization dynamics are linked to the
peptide’s antimicrobial activity.SUPPORTING MATERIAL
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